In this report, we demonstrate that baricitinib is an inhibitor of cytokines implicated in intensive care unit‐bound COVID‐19 patients, which have been collated from several reports, including IL‐2, IL‐6, IL‐10, IFN‐γ, and G‐CSF (Huang et al, 2020; Ruan et al, 2020; Zhou et al, 2020). The gene discussed is IL2; the disease is COVID-19.